SDX 0.00% 7.0¢ sienna cancer diagnostics limited

Sienna Apology, page-8

  1. 637 Posts.
    lightbulb Created with Sketch. 66
    My view is sales and licensing to expand US market 2017 and move into Europe 2017/18. R&D to commercialise other cancer diagnostics through 2020. Upside $100M market cap 2020 and happy days. I am holding and here for the ride. DYOR
 
watchlist Created with Sketch. Add SDX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.